Search results
AbbVie says FDA approves Skyrizi for ulcerative colitis
Market Watch· 2 hours agoDrug maker AbbVie Inc. on Tuesday said the Food and Drug Administration had approved its drug...
AbbVie (ABBV) Exceeds Market Returns: Some Facts to Consider
Zacks via Yahoo Finance· 3 hours agoThe latest trading session saw AbbVie (ABBV) ending at $171.36, denoting a +0.99% adjustment from...
AbbVie (NYSE:ABBV) Given New $190.00 Price Target at Piper Sandler
ETF DAILY NEWS· 13 hours agoAbbVie (NYSE:ABBV – Get Free Report) had its price objective boosted by research analysts at Piper Sandler from $185.00 to $190.00 in a research note issued on Tuesday, Benzinga ...
239 Shares in AbbVie Inc. (NYSE:ABBV) Bought by Ables Iannone Moore & Associates Inc.
ETF DAILY NEWS· 14 hours agoAbles Iannone Moore & Associates Inc. bought a new stake in AbbVie Inc. (NYSE:ABBV – Free Report) during the fourth quarter, according to the company in its most recent disclosure ...
AbbVie's Skyrizi Gets FDA Approval to Treat Certain Instances of Ulcerative Colitis
Market Watch· 2 hours agoPublished: June 18, 2024 at 6:36 p.m. ETShareResizeBy Sabela OjeaAbout Dow Jones NewswiresDow Jones Newswires is a market-moving financial and business news source, used by wealth managers, ...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Vanguard Group Inc.
ETF DAILY NEWS· 16 hours agoVanguard Group Inc. trimmed its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 0.2% during the 4th quarter, according to its most recent filing with the Securities and ...
B. Riley Wealth Advisors Inc. Sells 15,193 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 15 hours agoB. Riley Wealth Advisors Inc. trimmed its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 10.4% during the fourth quarter, Holdings Channel.com reports. The ...
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 6 days agoAbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want...
Walden Wealth Partners LLC Purchases New Shares in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 15 hours agoWalden Wealth Partners LLC acquired a new position in AbbVie Inc. (NYSE:ABBV – Free Report) during the fourth quarter, according to the company in its most recent Form 13F ...
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio...
FOX 23 News Albany· 2 hours agoFood and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for adults with moderately to severely active ulcerative colitis, making it the first IL...